pillbase.ru

Calquence

Active substance: acalabrutinib

acalabrutinib

Centralised EU authorisationActive

Marketing holder: AstraZeneca AB

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 3
  • CALQUENCE
    CAPSULE, GELATIN COATED · ACALABRUTINIB 100 mg/1
    0310-0512
    AstraZeneca Pharmaceuticals LP
  • CALQUENCE
    TABLET, FILM COATED · ACALABRUTINIB 100 mg/1
    0310-4513
    AstraZeneca Pharmaceuticals LP
  • CALQUENCE
    TABLET, FILM COATED · ACALABRUTINIB 100 mg/1
    0310-3512
    AstraZeneca Pharmaceuticals LP
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-94c9-797d-acfc-ac2988e85830,01a12094-2af3-7a6a-9984-3fca116aafc1,01a12096-da0d-71f4-833d-20257b405ad5;count=3 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/005299
Registration status
Active
ATC code
L01EL02
Sources
  • product · EMA · EMEA/H/C/005299 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/005299 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/005299 · Verified 2026-10-09